The Top 10 Most Significant FDA New Lab Test Approvals of 2022
Here are what G2 Intelligence considers to be the 10 most significant FDA lab testing clearances of 2022, in rough chronological order.
Here are what G2 Intelligence considers to be the 10 most significant FDA lab testing clearances of 2022, in rough chronological order.
The total market for PCR products will likely top $5 billion in 2023, according to a new report.
M&A activity in the clinical diagnostics space was significantly down in 2022 in terms of both deal volume and deal value.
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.